Frontiers in Immunology (Jul 2022)
Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation
- Kevin Baßler,
- Wataru Fujii,
- Theodore S. Kapellos,
- Erika Dudkin,
- Nico Reusch,
- Ari Horne,
- Benedikt Reiz,
- Malte D. Luecken,
- Collins Osei-Sarpong,
- Stefanie Warnat-Herresthal,
- Lorenzo Bonaguro,
- Lorenzo Bonaguro,
- Lorenzo Bonaguro,
- Jonas Schulte-Schrepping,
- Allon Wagner,
- Allon Wagner,
- Patrick Günther,
- Carmen Pizarro,
- Tina Schreiber,
- Rainer Knoll,
- Rainer Knoll,
- Rainer Knoll,
- Lisa Holsten,
- Charlotte Kröger,
- Charlotte Kröger,
- Elena De Domenico,
- Elena De Domenico,
- Matthias Becker,
- Matthias Becker,
- Kristian Händler,
- Kristian Händler,
- Christian T. Wohnhaas,
- Florian Baumgartner,
- Meike Köhler,
- Heidi Theis,
- Heidi Theis,
- Michael Kraut,
- Michael Kraut,
- Marc H. Wadsworth,
- Marc H. Wadsworth,
- Travis K. Hughes,
- Humberto J. Ferreira,
- Emily Hinkley,
- Emily Hinkley,
- Ines H. Kaltheuner,
- Matthias Geyer,
- Christoph Thiele,
- Alex K. Shalek,
- Alex K. Shalek,
- Andreas Feißt,
- Daniel Thomas,
- Henning Dickten,
- Marc Beyer,
- Marc Beyer,
- Marc Beyer,
- Patrick Baum,
- Nir Yosef,
- Nir Yosef,
- Nir Yosef,
- Nir Yosef,
- Anna C. Aschenbrenner,
- Anna C. Aschenbrenner,
- Anna C. Aschenbrenner,
- Thomas Ulas,
- Thomas Ulas,
- Thomas Ulas,
- Jan Hasenauer,
- Jan Hasenauer,
- Fabian J. Theis,
- Fabian J. Theis,
- Dirk Skowasch,
- Joachim L. Schultze,
- Joachim L. Schultze,
- Joachim L. Schultze
Affiliations
- Kevin Baßler
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Wataru Fujii
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Theodore S. Kapellos
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Erika Dudkin
- Computational Life Sciences, Life & Medical Sciences (LIMES) Institute, University of Bonn, Neuherberg, Germany
- Nico Reusch
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Ari Horne
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Benedikt Reiz
- Comma Soft AG, Bonn, Germany
- Malte D. Luecken
- Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Computational Biology, Neuherberg, Germany
- Collins Osei-Sarpong
- Immunogenomics & Neurodegeneration, German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany
- Stefanie Warnat-Herresthal
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Lorenzo Bonaguro
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Lorenzo Bonaguro
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Lorenzo Bonaguro
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Jonas Schulte-Schrepping
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Allon Wagner
- Department of electrical engineering and computer science, University of California, Berkeley, CA, United States
- Allon Wagner
- Center for computational biology, University of California, Berkeley, CA, United States
- Patrick Günther
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Carmen Pizarro
- 0Department of Internal Medicine II, University Hospital Bonn, Section of Pneumology, Bonn, Germany
- Tina Schreiber
- 0Department of Internal Medicine II, University Hospital Bonn, Section of Pneumology, Bonn, Germany
- Rainer Knoll
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Rainer Knoll
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Rainer Knoll
- 1Prevention, Aging & Systems Immunology, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany
- Lisa Holsten
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Charlotte Kröger
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Charlotte Kröger
- 1Prevention, Aging & Systems Immunology, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany
- Elena De Domenico
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Elena De Domenico
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Matthias Becker
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Matthias Becker
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Kristian Händler
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Kristian Händler
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Christian T. Wohnhaas
- 2Computational Biology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
- Florian Baumgartner
- Comma Soft AG, Bonn, Germany
- Meike Köhler
- Comma Soft AG, Bonn, Germany
- Heidi Theis
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Heidi Theis
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Michael Kraut
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Michael Kraut
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Marc H. Wadsworth
- 3Institute for Medical Engineering & Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States
- Marc H. Wadsworth
- 4Broad Institute of MIT and Harvard; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
- Travis K. Hughes
- 5Institute of Structural Biology, University Hospital, University of Bonn, Bonn, Germany
- Humberto J. Ferreira
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Emily Hinkley
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Emily Hinkley
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Ines H. Kaltheuner
- 5Institute of Structural Biology, University Hospital, University of Bonn, Bonn, Germany
- Matthias Geyer
- 6Biochemistry & Cell Biology of Lipids, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Christoph Thiele
- 7University Clinics for Radiology, University Hospital Bonn, Bonn, Germany
- Alex K. Shalek
- 3Institute for Medical Engineering & Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States
- Alex K. Shalek
- 4Broad Institute of MIT and Harvard; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
- Andreas Feißt
- 7University Clinics for Radiology, University Hospital Bonn, Bonn, Germany
- Daniel Thomas
- 7University Clinics for Radiology, University Hospital Bonn, Bonn, Germany
- Henning Dickten
- Comma Soft AG, Bonn, Germany
- Marc Beyer
- Immunogenomics & Neurodegeneration, German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany
- Marc Beyer
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Marc Beyer
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Patrick Baum
- 8Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
- Nir Yosef
- Department of electrical engineering and computer science, University of California, Berkeley, CA, United States
- Nir Yosef
- Center for computational biology, University of California, Berkeley, CA, United States
- Nir Yosef
- 9Chan-Zuckerberg Biohub, San Francisco, CA, United States
- Nir Yosef
- 0Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, United States
- Anna C. Aschenbrenner
- 1Prevention, Aging & Systems Immunology, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany
- Anna C. Aschenbrenner
- 0Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, United States
- Anna C. Aschenbrenner
- 1Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, Netherlands
- Thomas Ulas
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Thomas Ulas
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Thomas Ulas
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Jan Hasenauer
- Computational Life Sciences, Life & Medical Sciences (LIMES) Institute, University of Bonn, Neuherberg, Germany
- Jan Hasenauer
- Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Computational Biology, Neuherberg, Germany
- Fabian J. Theis
- Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Computational Biology, Neuherberg, Germany
- Fabian J. Theis
- 2School of Life Sciences Weihenstephan, Technical University of Munich, Munich, Germany, Department of Mathematics, Technical University of Munich, Munich, Germany
- Dirk Skowasch
- 0Department of Internal Medicine II, University Hospital Bonn, Section of Pneumology, Bonn, Germany
- Joachim L. Schultze
- Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany
- Joachim L. Schultze
- PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany
- Joachim L. Schultze
- Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- DOI
- https://doi.org/10.3389/fimmu.2022.917232
- Journal volume & issue
-
Vol. 13
Abstract
Despite its high prevalence, the cellular and molecular mechanisms of chronic obstructive pulmonary disease (COPD) are far from being understood. Here, we determine disease-related changes in cellular and molecular compositions within the alveolar space and peripheral blood of a cohort of COPD patients and controls. Myeloid cells were the largest cellular compartment in the alveolar space with invading monocytes and proliferating macrophages elevated in COPD. Modeling cell-to-cell communication, signaling pathway usage, and transcription factor binding predicts TGF-β1 to be a major upstream regulator of transcriptional changes in alveolar macrophages of COPD patients. Functionally, macrophages in COPD showed reduced antigen presentation capacity, accumulation of cholesteryl ester, reduced cellular chemotaxis, and mitochondrial dysfunction, reminiscent of impaired immune activation.
Keywords
- chronic obstructive pulmonary disease
- bronchoalveolar lavage
- blood
- macrophage
- monocyte
- impaired immune activation